Tetrahydropyran derivatives and their use as therapeutic agents
    8.
    发明授权
    Tetrahydropyran derivatives and their use as therapeutic agents 失效
    四氢吡喃衍生物及其作为治疗剂的用途

    公开(公告)号:US07265110B2

    公开(公告)日:2007-09-04

    申请号:US10488842

    申请日:2002-09-06

    CPC分类号: C07D405/04 C07D413/04

    摘要: The present invention relates compounds of the formula (I); wherein R1, R2, R3, R4, R5, R6, R7, R8, and R10 represent a variety of substituents; A represents NR9 or O; B represents a bond, CH2, NR9 or O, wherein one or both hydrogen atoms in said CH2 moiety may be replaced with one or both of R7 and R8, or alternatively, one of the hydrogen atoms in said CH2 moiety together with a hydrogen atom from an adjacent carbon are replaced by a double bond; with the proviso that when A is O, then B is NR9; n is zero, 1 or 2; and pharmaceutically acceptable salts thereof. The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migaine, emesis or postherpetic neuralgia

    摘要翻译: 本发明涉及式(I)化合物: 其中R 1,R 2,R 3,R 4,R 5, ,R 6,R 7,R 8和R 10代表各种取代基; A表示NR 9或O; B表示键,CH 2,NR 9或O,其中所述CH 2 H 2部分中的一个或两个氢原子可以被一个 或R 7和R 8两者,或者,所述CH 2 2部分中的一个氢原子与来自 相邻的碳被双键取代; 条件是当A为O时,B为NR 9; n为零,1或2; 及其药学上可接受的盐。 这些化合物特别用于治疗或预防抑郁,焦虑,疼痛,炎症,迁移物,呕吐或带状疱疹后神经痛